Cognitive-Behavioural Therapy as a Preventive Treatment for Post Traumatic Stress Disorder
NCT ID: NCT03116165
Last Updated: 2018-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
352 participants
INTERVENTIONAL
2017-04-18
2017-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Internet-delivered Cognitive-behavioral Intervention Provided Soon After Trauma: a RCT
NCT04101942
Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD
NCT05934162
An Internet-delivered Cognitive-behavioral Intervention Provided Soon After Trauma
NCT03850639
Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder
NCT05934175
Condensed Digital Prolonged Exposure for Individuals Treated Within Somatic Trauma Care.
NCT06318195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will first undergo an evaluation session that will include an interview (Immediate Stress Reaction Checklist) and questionnaires. Participants will subsequently be randomly assigned to receive either modified prolonged exposure therapy or attention control, starting the assigned intervention immediately. Participants in each arm will receive three weekly treatment sessions. Treatment will involve psychoeducation about common reactions to trauma, imaginal exposure (revisiting memories of a recent trauma out loud with a therapist and audio-recording these for review at home), exposure in vivo and breathing retraining. All participants will undergo assessments 2, 6 (primary endpoint) and 12 months after the intervention by blinded assessors. Patients unable to come to the clinic for follow-up assessments will be interviewed via telephone or skype. Source data will be quality monitored by an independent party (Karolinska trial alliance) according to the Helsinki Declaration.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Attention control
Participants will receive three sessions of supportive counselling and psychoeducation
Attention control
Participants will receive three sessions of supportive counselling and psychoeducation
Modified prolonged exposure therapy
Participants will receive three sessions of modified prolonged exposure therapy.
Modified prolonged exposure therapy
Participants will receive three sessions of modified prolonged exposure therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modified prolonged exposure therapy
Participants will receive three sessions of modified prolonged exposure therapy.
Attention control
Participants will receive three sessions of supportive counselling and psychoeducation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets diagnostic criterion A for post-traumatic stress disorder in the fifth version of Diagnostic and Statistical Manual of Mental Disorders, DSM-5
Exclusion Criteria
* Ongoing intoxication (e.g. severe alcohol intoxication)
* Other serious psychiatric comorbidity that demands attention (e.g. manic episode, acute suicidal ideation)
* Not oriented
* Not having a memory ot the tramatic event
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erik Andersson
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPN 2015/1820-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.